Peiling Li (Hao Wang)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Gene Expression

Top Venues

Journal of gynecologic oncology

Cell death & disease

International Peace Maternity and Child Health Hospital

Second Affiliated Hospital of Harbin Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

International Peace Maternity and Child Health Hospital Aug 01 2019

China

Resident :: Gynecology and Obstericts

Education History

Second Affiliated Hospital of Harbin Medical University Aug 01 2015 - Dec 28 2018

China

PHD :: Gynecology Oncology

Publications

Peiling Li, Yinuo Li, Yanan Wang, Xiumin Shang, Zhongxin Yan, Shengli Li, Wei Bao
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis. Journal of gynecologic oncology (2023)
Shan Zhu, Chunliu Zhang, Dongyan Cao, Jing Bai, Shuangni Yu, Jie Chen, Jing Wang, Tong Ren, Jiaxin Yang, Mei Yu, Xiao Xiao, Yuhua Gong, Yanfang Guan, Peiling Li, Ying Yue, Rutie Yin, Yongjun Wang, Ruifang An, Ge Lou, Jianlin Yuan, Guonan Zhang, Xuefeng Xia, Ling Yang, Yang Xiang
Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes. Oncogene 41 (22) (2022)
Hao Wang, Lei Fang, Jing Jiang, Ye Kuang, Beidi Wang, Xiumin Shang, Peilin Han, Yue Li, Meimei Liu, Zongfeng Zhang, Peiling Li
The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Cell death & disease 9 (11) (2018)